Evidence map›Paper›PMID 24757504›Full record

ArticleComputational and structural biotechnology journal2014

Site-specific Labeling of a Protein Lysine Residue By Novel Kinetic Labeling Combinatorial Libraries.

Allen Krantz, Arthur M Hanel, Ivona Strug, Andrzej Wilczynski, Jeremy J Wolff, Wolin Huang, Linda H Huang, Tina Settineri, Darren L Holmes, Margaret C Hardy and 1 more

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Allen KrantzAdvanced Proteome Therapeutics Inc., 650 Albany Street, Suite 113, Boston, MA 02118, United States ; RedCell Inc., 270-B Littlefield Avenue, South San Francisco, CA, 94080, United States (Renamed ConjuChem LLC. Current address: 11755 Wilshire Blvd, Suite 2000, Los Angeles, CA 90025.).
Arthur M HanelRedCell Inc., 270-B Littlefield Avenue, South San Francisco, CA, 94080, United States (Renamed ConjuChem LLC. Current address: 11755 Wilshire Blvd, Suite 2000, Los Angeles, CA 90025.).
Ivona StrugAdvanced Proteome Therapeutics Inc., 650 Albany Street, Suite 113, Boston, MA 02118, United States ; Current address: EMD Millipore, 17 Cherry Hill Drive, Danvers, Massachusetts, 01923, United States.
Andrzej WilczynskiAdvanced Proteome Therapeutics Inc., 650 Albany Street, Suite 113, Boston, MA 02118, United States.
Jeremy J WolffBruker Daltonics Inc., 40 Manning Road, Billerica, MA 01821, United States.
Wolin HuangRedCell Inc., 270-B Littlefield Avenue, South San Francisco, CA, 94080, United States (Renamed ConjuChem LLC. Current address: 11755 Wilshire Blvd, Suite 2000, Los Angeles, CA 90025.).
Linda H HuangRedCell Inc., 270-B Littlefield Avenue, South San Francisco, CA, 94080, United States (Renamed ConjuChem LLC. Current address: 11755 Wilshire Blvd, Suite 2000, Los Angeles, CA 90025.).
Tina SettineriRedCell Inc., 270-B Littlefield Avenue, South San Francisco, CA, 94080, United States (Renamed ConjuChem LLC. Current address: 11755 Wilshire Blvd, Suite 2000, Los Angeles, CA 90025.) ; Current address: Thermo Fisher Scientific, 355 River Oaks Parkway, San Jose, CA 95134, United States.
Darren L HolmesRedCell Inc., 270-B Littlefield Avenue, South San Francisco, CA, 94080, United States (Renamed ConjuChem LLC. Current address: 11755 Wilshire Blvd, Suite 2000, Los Angeles, CA 90025.).
Margaret C HardyRedCell Inc., 270-B Littlefield Avenue, South San Francisco, CA, 94080, United States (Renamed ConjuChem LLC. Current address: 11755 Wilshire Blvd, Suite 2000, Los Angeles, CA 90025.).
Dominique P BridonRedCell Inc., 270-B Littlefield Avenue, South San Francisco, CA, 94080, United States (Renamed ConjuChem LLC. Current address: 11755 Wilshire Blvd, Suite 2000, Los Angeles, CA 90025.) ; Current address: Optivia Biotechnology Inc., 115 Constitution Drive, Suite 7, Menlo Park, CA 94025, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The first example of a kinetic labeling library designed to enable the discovery of affinity labels is presented. Each library component (1) consists of a variable peptidyl component linked to a biotinyl moiety by a 4-mercaptobenzoyl linker in thioester format. We demonstrate that an affinity label can be uncovered by measuring reaction rates between library pools and the protein target, human serum albumin (HSA) and identifying significant outliers. By choosing peptide functionality compatible with a potentially reactive thioester labeling entity, libraries can be screened in pools. It is noteworthy that a limited subset of amino acids (R, S, E, F, Y, l, M, W, and Q) that compose the affinity moiety is sufficient to produce rate variances that guide the discovery process. After two rounds of deconvolution, J-FLYEE-NH2 (7-E) emerges as a bona fide affinity label of HSA. Unlike known affinity labels, the affinity moiety is not retained in the protein product, but is extruded upon acylation of the protein. This feature affords a method of introducing various payloads, without extraneous elements, onto protein frameworks.

Indexed as

Affinity labelsCombinatorial librariesKinetic labeling librariesLysine labelingPeptide librariesSite-specific protein modification

Identifiers

PMID24757504
PMCPMC3995232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.